Beasley Allen has filed an opioid lawsuit against drug manufacturers and distributors on behalf of the City of Abbeville, Alabama, alleging the marketing of these drugs contributed to the creation of the opioid epidemic, a public health and safety crisis. Responding to the opioid crisis has required the city to sustain economic damages and to continue to bear a significant financial burden. The City of Abbeville is represented by Beasley Allen lawyers Rhon E. Jones, who is head of the firm’s Toxic Torts Section, Rick Stratton, Will Sutton and Ryan Kral, along with local attorney, Spencer W. Danzey of The Danzey Firm, P.C.
Beasley Allen has filed similar lawsuits on behalf of the City of Greenville, Houston County, Barbour County, Limestone County, City of Anniston, City of Evergreen, City of Georgiana, Town of McKenzie and the Town of Yellow Bluff, Alabama, as well as Sumner County, Tennessee. The firm also is representing the State of Alabama in its opioid lawsuit against Purdue Pharmaceuticals.
“Pharmaceutical companies unleashed a scourge that has become known as the national opioid epidemic,” said Jones. “As it has echoed across our country, leaving sadness and brokenness in its wake, communities have been left to pick up and put the pieces back together. It has cost them billions – $504 billion – annually to combat the ills of opioid addiction and put a strain on local resources.”
“You can’t put a price tag on a human life, but cities like Abbeville have watched as their costs to care for residents fighting addiction have soared,” Danzey said. “While Big Pharma was lining its greedy pockets, and holding their hands out for even more profits, the City of Abbeville was hurting. Local resources had to be diverted to address the public safety and other concerns created by the epidemic. It is time for those responsible for creating the problem to reimburse local governments and taxpayers.”
Economic damages resulting from the opioid epidemic include costs for providing medical care, therapeutic care and treatments for patients suffering from opioid-related addiction or disease, including overdoses and deaths; costs for providing counseling and rehabilitation services; costs for treating infants born with opioid-related medical conditions; public safety and law enforcement expenses; and care for children whose parents suffer from opioid-related disability or incapacitation.
In 2016, Henry County, where the City of Abbeville is located, had an opioid prescription rate of 30.7 for every 100 people. Nationally, opioids are responsible for killing more than 183,000 people since 1999, according to the Centers for Disease Control and Prevention (CDC). In 2016 alone, 42,000 people in the U.S. died from opioid overdoses.
Defendants include Purdue Pharma L.P.; Purdue Pharma, Inc.; The Purdue Frederick Company, Inc.; Teva Pharmaceutical Industries, LTD.; Teva Pharmaceuticals USA, Inc.; Cephalon, Inc.; Johnson & Johnson; Janssen Pharmaceuticals, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc. n/k/a Janssen Pharmaceuticals, Inc.; Janssen Pharmaceutical Inc. n/k/a Janssen Pharmaceuticals, Inc.; Noramco, Inc.; Endo Health Solutions Inc.; Endo Pharmaceuticals, Inc.; Allergan PLC f/k/a Actavis PLS; Watson Pharmaceuticals, Inc. n/k/a Actavis, Inc.; Watson Laboratories, Inc.; Actavis, LLC; Actavis Pharm a, Inc. f/k/a Watson Pharma, Inc.; Mallinckrodt plc; Mallinckrodt LLC; McKesson Corporation; Cardinal Health, Inc.; and AmerisourceBergen Drug Corporation.
The complaint is filed in the U.S. District Court for the Middle District of Alabama, Southern Division.